Jennifer Lattanze

955 total citations
11 papers, 411 citations indexed

About

Jennifer Lattanze is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Jennifer Lattanze has authored 11 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Immunology and Allergy. Recurrent topics in Jennifer Lattanze's work include Cancer-related Molecular Pathways (6 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Cell Adhesion Molecules Research (3 papers). Jennifer Lattanze is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Cell Adhesion Molecules Research (3 papers). Jennifer Lattanze collaborates with scholars based in United States. Jennifer Lattanze's co-authors include Tianbao Lu, Maxwell D. Cummings, Raul R. Calvo, Daniel J. Parks, Karen L. Milkiewicz, Louis V. LaFrance, Juan Marugán, Pierre Raboisson, Carsten J. Schubert and Bruce Grasberger and has published in prestigious journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Chemical Biology & Drug Design.

In The Last Decade

Jennifer Lattanze

11 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Lattanze United States 10 267 188 176 49 48 11 411
Louis V. LaFrance United States 5 259 1.0× 134 0.7× 204 1.2× 52 1.1× 39 0.8× 8 366
Karen L. Milkiewicz United States 14 384 1.4× 266 1.4× 281 1.6× 52 1.1× 62 1.3× 19 649
Henriëtte M. G. Willems United Kingdom 13 317 1.2× 200 1.1× 157 0.9× 42 0.9× 91 1.9× 24 512
Pascal Furet Switzerland 7 397 1.5× 189 1.0× 247 1.4× 41 0.8× 60 1.3× 7 565
Diane Maguire United States 6 175 0.7× 168 0.9× 125 0.7× 33 0.7× 29 0.6× 6 360
Carole Pissot‐Soldermann Switzerland 9 167 0.6× 181 1.0× 138 0.8× 25 0.5× 26 0.5× 10 384
Maria Gabriella Brasca Italy 17 345 1.3× 276 1.5× 186 1.1× 91 1.9× 82 1.7× 28 663
Till Rehm Germany 6 324 1.2× 96 0.5× 182 1.0× 62 1.3× 20 0.4× 6 436
Kazuhiro Fukasawa Japan 11 345 1.3× 183 1.0× 203 1.2× 68 1.4× 75 1.6× 19 538
David Bartkovitz United States 7 427 1.6× 118 0.6× 356 2.0× 69 1.4× 27 0.6× 7 604

Countries citing papers authored by Jennifer Lattanze

Since Specialization
Citations

This map shows the geographic impact of Jennifer Lattanze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Lattanze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Lattanze more than expected).

Fields of papers citing papers by Jennifer Lattanze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Lattanze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Lattanze. The network helps show where Jennifer Lattanze may publish in the future.

Co-authorship network of co-authors of Jennifer Lattanze

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Lattanze. A scholar is included among the top collaborators of Jennifer Lattanze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Lattanze. Jennifer Lattanze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Raboisson, Pierre, Renée L. DesJarlais, Jennifer Lattanze, et al.. (2007). Identification of Novel Short Chain 4‐Substituted Indoles as Potent ανβ3 Antagonist Using Structure‐Based Drug Design.. ChemInform. 38(30). 1 indexed citations
2.
Raboisson, Pierre, Carl L. Manthey, Margery A. Chaikin, et al.. (2006). Novel potent and selective αvβ3/αvβ5 integrin dual antagonists with reduced binding affinity for human serum albumin. European Journal of Medicinal Chemistry. 41(7). 847–861. 10 indexed citations
3.
Raboisson, Pierre, Renée L. DesJarlais, Jennifer Lattanze, et al.. (2006). Identification of novel short chain 4-substituted indoles as potent αvβ3 antagonist using structure-based drug design. European Journal of Medicinal Chemistry. 42(3). 334–343. 18 indexed citations
4.
Patch, Raymond J., Christian A. Baumann, Jian Liu, et al.. (2006). Identification of 2-acylaminothiophene-3-carboxamides as potent inhibitors of FLT3. Bioorganic & Medicinal Chemistry Letters. 16(12). 3282–3286. 25 indexed citations
5.
Cummings, Maxwell D., Carsten J. Schubert, Daniel J. Parks, et al.. (2006). Substituted 1,4‐Benzodiazepine‐2,5‐diones as α‐Helix Mimetic Antagonists of the HDM2‐p53 Protein–Protein Interaction. Chemical Biology & Drug Design. 67(3). 201–205. 37 indexed citations
6.
Leonard, Kristi, Juan Marugán, Pierre Raboisson, et al.. (2006). Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity. Bioorganic & Medicinal Chemistry Letters. 16(13). 3463–3468. 49 indexed citations
7.
Parks, Daniel J., Louis V. LaFrance, Raul R. Calvo, et al.. (2006). Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein–protein interaction through structure-based drug design. Bioorganic & Medicinal Chemistry Letters. 16(12). 3310–3314. 57 indexed citations
8.
Marugán, Juan, Kristi Leonard, Pierre Raboisson, et al.. (2006). Enantiomerically pure 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(12). 3115–3120. 23 indexed citations
9.
Leonard, Kristi, Wenxi Pan, Renée L. DesJarlais, et al.. (2005). Non-peptidic αvβ3 antagonists containing indol-1-yl propionic acids. Bioorganic & Medicinal Chemistry Letters. 15(10). 2679–2684. 20 indexed citations
10.
Raboisson, Pierre, Juan Marugán, Carsten J. Schubert, et al.. (2005). Structure-based design, synthesis, and biological evaluation of novel 1,4-diazepines as HDM2 antagonists. Bioorganic & Medicinal Chemistry Letters. 15(7). 1857–1861. 41 indexed citations
11.
Parks, Daniel J., Louis V. LaFrance, Raul R. Calvo, et al.. (2004). 1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR. Bioorganic & Medicinal Chemistry Letters. 15(3). 765–770. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis V. LaFrance Breakdown of academic impact, for papers by Karen L. Milkiewicz Breakdown of academic impact, for papers by Henriëtte M. G. Willems Breakdown of academic impact, for papers by Pascal Furet Breakdown of academic impact, for papers by Diane Maguire Breakdown of academic impact, for papers by Carole Pissot‐Soldermann Breakdown of academic impact, for papers by Maria Gabriella Brasca Breakdown of academic impact, for papers by Till Rehm Breakdown of academic impact, for papers by Kazuhiro Fukasawa Breakdown of academic impact, for papers by David Bartkovitz
Rankless by CCL
2026